Virtus LifeSci Financial Statements From 2010 to 2024
| BBP Etf | USD 50.60 1.09 2.11% |
Check Virtus LifeSci financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Virtus main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Virtus financial statements analysis is a perfect complement when working with Virtus LifeSci Valuation or Volatility modules.
Virtus |
Virtus LifeSci Biotech ETF Beta Analysis
Virtus LifeSci's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Virtus LifeSci Beta | 0.65 |
Most of Virtus LifeSci's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virtus LifeSci Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Virtus LifeSci Biotech has a Beta of 0.65. This is much higher than that of the Virtus family and significantly higher than that of the Health category. The beta for all United States etfs is notably lower than that of the firm.
Virtus LifeSci Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Virtus LifeSci's current stock value. Our valuation model uses many indicators to compare Virtus LifeSci value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Virtus LifeSci competition to find correlations between indicators driving Virtus LifeSci's intrinsic value. More Info.Virtus LifeSci Biotech is fourth largest ETF in price to earning as compared to similar ETFs. It is fifth largest ETF in price to book as compared to similar ETFs fabricating about 0.09 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Virtus LifeSci Biotech is roughly 10.86 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Virtus LifeSci by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Virtus LifeSci's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Virtus LifeSci's earnings, one of the primary drivers of an investment's value.About Virtus LifeSci Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Virtus LifeSci income statement, its balance sheet, and the statement of cash flows. Virtus LifeSci investors use historical funamental indicators, such as Virtus LifeSci's revenue or net income, to determine how well the company is positioned to perform in the future. Although Virtus LifeSci investors may use each financial statement separately, they are all related. The changes in Virtus LifeSci's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Virtus LifeSci's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Virtus LifeSci Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Virtus LifeSci. Please read more on our technical analysis and fundamental analysis pages.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Virtus LifeSci in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Virtus LifeSci's short interest history, or implied volatility extrapolated from Virtus LifeSci options trading.
Pair Trading with Virtus LifeSci
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Virtus LifeSci position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virtus LifeSci will appreciate offsetting losses from the drop in the long position's value.Moving together with Virtus Etf
| 0.74 | IBB | iShares Biotechnology ETF | PairCorr |
Moving against Virtus Etf
| 0.66 | CIRC | JPMorgan | PairCorr |
| 0.63 | RSPY | Tuttle Capital Management | PairCorr |
| 0.45 | MSFT | Microsoft Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Virtus LifeSci could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Virtus LifeSci when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Virtus LifeSci - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Virtus LifeSci Biotech to buy it.
The correlation of Virtus LifeSci is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Virtus LifeSci moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Virtus LifeSci Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Virtus LifeSci can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Virtus LifeSci Correlation against competitors. Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.